The 2010 Government Supported Benefits 'Virtual' Summit
A unique web-based conference and series of accredited on-line self-learning programs focused on the impact of Heathcare reform on providers and patient care.
|
The 2010 Government Supported Benefits 'Virtual' Summit |
A unique web-based conference and series of accredited on-line self-learning programs focused on the impact of Heathcare reform on providers and patient care. |
|
The Impact of Reimbursement Strategies for Pediatric Asthma in Medicaid
Needs Assessment:
Pediatric asthma is associated with high healthcare utilization and cost in Medicaid programs. National asthma guidelines and the 2004 update recommend use of inhaled corticosteroids (ICS) as safe and effective for persistent asthma in children. The update advocates adjunctive long-acting beta(2)-adrenergic agonists in children with moderate or severe persistent asthma. Economically disadvantaged children enrolled in Medicaid plans have a high risk of asthma but are less likely to receive care in keeping with the guidelines, often receiving less preventive asthma care, more costly inpatient care. Shifts from fee for service to managed care has resulted in increases in outpatient asthma visits and the proportion of patients using ICS while reducing asthma-related healthcare utilization claims, hospitalizations, and emergency department visits. Provider and patient education programs can make a difference, but require constant reinforcement. Drug utilization reviews can identify inappropriate drug use and are mandated since the 1990 Omnibus Budget Reconciliation Act. Appropriate care of pediatric asthma is important due to the vulnerable nature of the patient population and the potential lifetime impact of the condition on costs and productivity.
Learning Objectives:
Following completion of this program, participants will be able to:
To understand the guidelines for the treatment of pediatric asthma and the subsequent updates
To understand the impact of patient and provider educational programs
To be familiar with the different agents used to treat pediatric asthma, their mechanisms of action, modes of administration, and effectiveness in the patient population.
To understand how asthma care is received under Medicaid Fee for Service and managed care plans and review the costs and consequences of inadequately controlled asthma
To participate in the debate of balancing access, cost and outcomes to improve patient care in pediatric asthma.
Agenda
Disclosures and Introduction (2 minutes)
Guidelines for the treatment of pediatric asthma and the subsequent updates (15 minutes)
The impact of patient and provider educational programs (10 minutes)
Agents used to treat pediatric asthma, their mechanisms of action, modes of administration, and effectiveness in the patient population (10 minutes)
Asthma care under Medicaid Fee for Service and managed care plans and review the costs and consequences of inadequately controlled asthma (10 minutes)
Balancing access, cost and outcomes to improve patient care in pediatric asthma (10 minutes)
References, Summary and Conclusions (3 min)